Filing Details

Accession Number:
0001209191-16-140360
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-09-07 11:37:15
Reporting Period:
2016-09-06
Filing Date:
2016-09-07
Accepted Time:
2016-09-07 11:37:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1415336 Zeltiq Aesthetics Inc ZLTQ Electromedical & Electrotherapeutic Apparatus (3845) 270119051
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1417973 J Keith Sullivan C/O Zeltiq Aesthetics, Inc.
4698 Willow Road, Suite 100
Pleasanton CA 94588
Cco, President, North America No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-09-06 8,000 $6.21 83,159 No 4 M Direct
Common Stock Disposition 2016-09-06 8,000 $38.36 75,159 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2016-09-06 8,000 $0.00 8,000 $6.21
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
106,000 2022-10-04 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,000 Indirect By Keith J Sullivan (IRA) FCC as custodian
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.09 to $38.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  3. 25% of the total number of shares subject to the option vested on October 4, 2013, and the remainder vest in equal monthly installments over a 36 month period thereafter, subject to the Reporting Person's continued service to the Issuer.